Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patientsMaryam B. Lustberg, Jeffrey J. Chalmers, Priya Balasubramanian et al.|Breast Cancer Research|2014Cited by 124
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, William E. Carson, Megan Duggan et al.|Cancer Immunology Immunotherapy|2017Cited by 72
Neoadjuvant Dual HER2-Targeted Therapy With Lapatinib and Trastuzumab Improves Pathologic Complete Response in Patients With Early Stage HER2-Positive Breast Cancer: A Meta-Analysis of Randomized Prospective Clinical TrialsMellissa Hicks, Robert Wesolowski, Rachel M. Layman et al.|The Oncologist|2015Cited by 48
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancerRachel M. Layman, Charles L. Shapiro, Amy S. Ruppert et al.|Cancer Chemotherapy and Pharmacology|2013Cited by 47
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Robert Wesolowski, Mohamed Badawi et al.|Investigational New Drugs|2020Cited by 37